The Food and Drug Administration has approved the use of a single pill containing two different antiviral drugs for the treatment for hepatitis C. It is the first combination pill approved for the disease, and also the first treatment that does not contain interferon or ribavirin. The new hepatitis C drug, called Harvoni, is a mixture …
I joined Marc Pelletier on episode 56 of Futures in Biotech for a conversation with Stanford University School of Medicine Professor Karla Kirkegaard. We talked about RNA viruses – where they came from, where they are going, and Dr. Kirkegaard’s unique approach to discovering antiviral drugs. Don’t miss this episode: Dr. Kirkegaard is a brilliant and …
The emergence of oseltamivir (Tamiflu)-resistant 2009 H1N1 influenza virus in a Canadian family illustrates the basic concept that viral loads depend on the dose of antiviral drug. Neuraminidase inhibitors like Tamiflu and Relenza are used to treat severe illness caused by the 2009 pandemic influenza A (H1N1) virus. The antiviral drugs may also be used …
Tamiflu-resistant pandemic influenza H1N1 virus selected by prophylaxis Read More »
